mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.049 |
0.4 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.4 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |